Scale Computing Unveils Scale Computing Platform (SC//Platform) as the Backbone of Decentralized AI and Agentic Computing at the Edge
LAS VEGAS, May 14, 2025 /PRNewswire/ — Scale Computing Platform Summit — As organizations accelerate toward agentic AI-driven operations, Scale... Read more.
Bench International Launches Bench On Demand to Deliver Executive Leadership at Fractional and Interim Capacity
SAN DIEGO, May 14, 2025 /PRNewswire/ — Bench International, the longest-serving woman-founded executive search firm in the life sciences industry, today announced... Read more.
Rewardian Debuts AI Recognition Assistant to Elevate Employee Engagement
ATLANTA, May 14, 2025 /PRNewswire/ — Rewardian, a leader in employee recognition technology, announces the launch of its AI Recognition Assistant, a... Read more.
SubtleHD™ Gains Health Canada Approval to Support MRI Efficiency Improvements
SubtleHD delivers breakthrough efficiency and image quality to address Canada’s urgent need for faster MRI access. MENLO PARK, Calif., May 14, 2025 /PRNewswire/... Read more.
INE Security Alert: Continuous CVE Practice Closes Critical Gap Between Vulnerability Alerts and Effective Defense
CARY, N.C., May 14, 2025 /PRNewswire/ — INE Security, a global leader in hands-on cybersecurity training and certifications, today highlighted how ongoing... Read more.
US Job Seekers Face Economic Fears, Increased Workloads and Growing Job Dissatisfaction
Survey Highlights Concerns Over Salary, Workforce Reduction and Impact of Technology OKLAHOMA CITY, May 14, 2025 /PRNewswire/ — A recent study of U.S. job... Read more.
Jacobs Appointed Integrated Delivery Partner for Marinus Link
Interconnector project will accelerate Australia’s renewable energy economy Supports reliable transmission of electricity and telecommunications between Tasmania... Read more.
ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML)
ZYNLONTA® plus glofitamab (COLUMVI®) demonstrated ORR of 95.5% and CR of 90.9%, among 22 evaluable patients with relapsed/refractory DLBCL Safety... Read more.
Palatin Reports Fiscal Year 2025 Third Quarter Results and Business Update
Significant Progress in Obesity and Ocular Programs Teleconference and Webcast to be held today – May 14, 2025, at 11:00 AM EST CRANBURY, N.J., May 14, 2025... Read more.
DeFi Technologies Inc. Announces Q1 2025 Financial Results: Revenues of C$62.7 million (US$43.1 million), EBITDA of $44.8 million (US$31.2 million) and Net Income of C$43 million (US$30 million), and Notable Strategic Developments
Revenues, EBITDA and Net Income: For the three months ended March 31, 2025, DeFi Technologies reported Revenues of C$62.7 million (US$43.1 million), EBITDA... Read more.